<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01309100</url>
  </required_header>
  <id_info>
    <org_study_id>672E</org_study_id>
    <nct_id>NCT01309100</nct_id>
  </id_info>
  <brief_title>Product Feasibility of a New Silicone Hydrogel Contact Lens</brief_title>
  <official_title>A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bausch &amp; Lomb Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine the clinical feasibility and to evaluate the
      product performance of investigational contact lens.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity (Investigational vs Air Optix Aqua Lens)</measure>
    <time_frame>1 week</time_frame>
    <description>The mean difference in distance high contrast logMAR visual acuity(VA) between the investigational lens (RD2117-01) and the Air Optix Aqua control lens.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity (Investigational vs Acuvue Oasys Lens)</measure>
    <time_frame>1 week</time_frame>
    <description>The mean difference in distance high contrast logMAR visual acuity(VA) between the investigational lens(RD2117-01) and the Acuvue Oasys control lens.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comfort Throughout the Day (Investigational vs Acuvue Oasys Lens)</measure>
    <time_frame>1 week</time_frame>
    <description>The mean differences in comfort between the investigational lens (RD2117-01) and the Acuvue Oasys control lens. Comfort was measured on a scale of 0 to 100, with 100 being the most favorable score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comfort Throughout the Day (Investigational vs Air Optix Aqua Lens)</measure>
    <time_frame>1 week</time_frame>
    <description>The mean differences in comfort between the investigational lens(RD2117-01) and the Air Optix Aqua control lens. Comfort was measured on a scale of 0 to 100, with 100 being the most favorable score.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">144</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Investigational Lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bausch &amp; Lomb investigational silicone hydrogel lens.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acuvue Oasys Lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Johnson &amp; Johnson Acuvue Oasys contact lens.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Air Optix Aqua Lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ciba Vision Air Optix Aqua contact lens.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Investigational Lens</intervention_name>
    <description>Bausch &amp; Lomb investigational silicone hydrogel lens on a daily wear basis for 1 week.</description>
    <arm_group_label>Investigational Lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acuvue Oasys Lens</intervention_name>
    <description>Johnson &amp; Johnson Acuvue Oasys contact lens on a daily wear basis for 1 week.</description>
    <arm_group_label>Acuvue Oasys Lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Air Optix Aqua Lens</intervention_name>
    <description>Ciba Vision Air Optix Aqua contact lens on a daily wear basis for 1 week.</description>
    <arm_group_label>Air Optix Aqua Lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects must have clear central corneas and be free of any anterior segment
             disorders.

          -  Subjects must be adapted wearers of soft contact lenses, wear a lens in each eye, and
             each lens must be of the same manufacture and brand.

          -  Subjects must be myopic and require lens correction

        Exclusion Criteria:

          -  Subjects with any systemic disease affecting ocular health.

          -  Subjects using any systemic or topical medications that will, in the Investigator's
             opinion, affect ocular physiology or lens performance.

          -  Subjects with an active ocular disease or are using any ocular medication.

          -  Subjects with any &quot;Present&quot; finding during the slit lamp examination that, in the
             Investigator's judgment, interferes with contact lens wear.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tara Vaz, OD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bausch &amp; Lomb Incorporated</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bausch &amp; Lomb Incorporated</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 3, 2011</study_first_submitted>
  <study_first_submitted_qc>March 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2011</study_first_posted>
  <results_first_submitted>March 27, 2014</results_first_submitted>
  <results_first_submitted_qc>March 27, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 29, 2014</results_first_posted>
  <last_update_submitted>March 27, 2014</last_update_submitted>
  <last_update_submitted_qc>March 27, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This was a randomized, bilateral, three-way crossover, subject-masked study conducted at six sites in the United States. The first participant was enrolled 11/8/2010 and last participant exited on 12/23/2010.</recruitment_details>
      <pre_assignment_details>144 participants were equally randomized to one of six treatment sequences. 142 participants completed the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Overall Study</title>
          <description>Participants were equally randomized to one of 6 treatment sequences: RD2117-01, Air Optix Aqua, Acuvue Oasys; RD2117-01, Acuvue Oasys, Air Optix Aqua; Air Optix Aqua, RD2117-01, Acuvue Oasys; Air Optix Aqua, Acuvue Oasys, RD2117-01; Acuvue Oasys, RD2117-01, Air Optix Aqua; Acuvue Oasys, Air Optix Aqua, RD2117-01. All participants wore each of the 3 lenses for one week.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="144"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="142"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Positive Slit lamp finding</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All randomized participants</population>
      <group_list>
        <group group_id="B1">
          <title>Overall Study</title>
          <description>Participants were equally randomized to one of 6 treatment sequences: RD2117-01, Air Optix Aqua, Acuvue Oasys; RD2117-01, Acuvue Oasys, Air Optix Aqua; Air Optix Aqua, RD2117-01, Acuvue Oasys; Air Optix Aqua, Acuvue Oasys, RD2117-01; Acuvue Oasys, RD2117-01, Air Optix Aqua; Acuvue Oasys, Air Optix Aqua, RD2117-01. All participants wore each of the 3 lenses for one week.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="144"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.6" spread="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="144"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity (Investigational vs Air Optix Aqua Lens)</title>
        <description>The mean difference in distance high contrast logMAR visual acuity(VA) between the investigational lens (RD2117-01) and the Air Optix Aqua control lens.</description>
        <time_frame>1 week</time_frame>
        <population>All eligible, dispensed eyes</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational Lens</title>
            <description>Bausch &amp; Lomb investigational silicone hydrogel lens (RD2117-01).
Investigational Lens: Bausch &amp; Lomb investigational silicone hydrogel lens on a daily wear basis for 1 week.</description>
          </group>
          <group group_id="O2">
            <title>Air Optix Aqua Lens</title>
            <description>Ciba Vision Air Optix Aqua contact lens.
Air Optix Aqua Lens: Ciba Vision Air Optix Aqua contact lens on a daily wear basis for 1 week.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity (Investigational vs Air Optix Aqua Lens)</title>
          <description>The mean difference in distance high contrast logMAR visual acuity(VA) between the investigational lens (RD2117-01) and the Air Optix Aqua control lens.</description>
          <population>All eligible, dispensed eyes</population>
          <units>LogMAR</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
                <count group_id="O2" value="143"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="286"/>
                <count group_id="O2" value="286"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.050" spread="0.116"/>
                    <measurement group_id="O2" value="-0.060" spread="0.116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Week follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.034" spread="0.111"/>
                    <measurement group_id="O2" value="-0.039" spread="0.111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comfort Throughout the Day (Investigational vs Acuvue Oasys Lens)</title>
        <description>The mean differences in comfort between the investigational lens (RD2117-01) and the Acuvue Oasys control lens. Comfort was measured on a scale of 0 to 100, with 100 being the most favorable score.</description>
        <time_frame>1 week</time_frame>
        <population>1-Week Follow-up, All Eligible, Dispensed Eyes</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational Lens</title>
            <description>Bausch &amp; Lomb investigational silicone hydrogel lens(RD2117-01).
Investigational Lens: Bausch &amp; Lomb investigational silicone hydrogel lens on a daily wear basis for 1 week.</description>
          </group>
          <group group_id="O2">
            <title>Acuvue Oasys Lens</title>
            <description>Johnson &amp; Johnson Acuvue Oasys contact lens.
Acuvue Oasys Lens: Johnson &amp; Johnson Acuvue Oasys contact lens on a daily wear basis for 1 week.</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort Throughout the Day (Investigational vs Acuvue Oasys Lens)</title>
          <description>The mean differences in comfort between the investigational lens (RD2117-01) and the Acuvue Oasys control lens. Comfort was measured on a scale of 0 to 100, with 100 being the most favorable score.</description>
          <population>1-Week Follow-up, All Eligible, Dispensed Eyes</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
                <count group_id="O2" value="143"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="286"/>
                <count group_id="O2" value="286"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.9" spread="21.4"/>
                    <measurement group_id="O2" value="86.5" spread="21.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity (Investigational vs Acuvue Oasys Lens)</title>
        <description>The mean difference in distance high contrast logMAR visual acuity(VA) between the investigational lens(RD2117-01) and the Acuvue Oasys control lens.</description>
        <time_frame>1 week</time_frame>
        <population>All eligible, dispensed eyes</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational Lens</title>
            <description>Bausch &amp; Lomb investigational silicone hydrogel lens(RD2117-01).
Investigational Lens: Bausch &amp; Lomb investigational silicone hydrogel lens on a daily wear basis for 1 week.</description>
          </group>
          <group group_id="O2">
            <title>Acuvue Oasys Lens</title>
            <description>Johnson &amp; Johnson Acuvue Oasys contact lens.
Acuvue Oasys Lens: Johnson &amp; Johnson Acuvue Oasys contact lens on a daily wear basis for 1 week.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity (Investigational vs Acuvue Oasys Lens)</title>
          <description>The mean difference in distance high contrast logMAR visual acuity(VA) between the investigational lens(RD2117-01) and the Acuvue Oasys control lens.</description>
          <population>All eligible, dispensed eyes</population>
          <units>LogMAR</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
                <count group_id="O2" value="143"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="286"/>
                <count group_id="O2" value="286"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.050" spread="0.113"/>
                    <measurement group_id="O2" value="-0.048" spread="0.113"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1-week follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.034" spread="0.109"/>
                    <measurement group_id="O2" value="-0.033" spread="0.109"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comfort Throughout the Day (Investigational vs Air Optix Aqua Lens)</title>
        <description>The mean differences in comfort between the investigational lens(RD2117-01) and the Air Optix Aqua control lens. Comfort was measured on a scale of 0 to 100, with 100 being the most favorable score.</description>
        <time_frame>1 week</time_frame>
        <population>All eligible, dispensed eyes</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational Lens</title>
            <description>Bausch &amp; Lomb investigational silicone hydrogel lens(RD2117-01).
Investigational Lens: Bausch &amp; Lomb investigational silicone hydrogel lens on a daily wear basis for 1 week.</description>
          </group>
          <group group_id="O2">
            <title>Air Optix Aqua Lens</title>
            <description>Ciba Vision Air Optix Aqua contact lens.
Air Optix Aqua Lens: Ciba Vision Air Optix Aqua contact lens on a daily wear basis for 1 week.</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort Throughout the Day (Investigational vs Air Optix Aqua Lens)</title>
          <description>The mean differences in comfort between the investigational lens(RD2117-01) and the Air Optix Aqua control lens. Comfort was measured on a scale of 0 to 100, with 100 being the most favorable score.</description>
          <population>All eligible, dispensed eyes</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
                <count group_id="O2" value="142"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="286"/>
                <count group_id="O2" value="284"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.9" spread="21.4"/>
                    <measurement group_id="O2" value="82.1" spread="21.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Overall Study</title>
          <description>Participants were equally randomized to one of 6 treatment sequences: RD2117-01, Air Optix Aqua, Acuvue Oasys; RD2117-01, Acuvue Oasys, Air Optix Aqua; Air Optix Aqua, RD2117-01, Acuvue Oasys; Air Optix Aqua, Acuvue Oasys, RD2117-01; Acuvue Oasys, RD2117-01, Air Optix Aqua; Acuvue Oasys, Air Optix Aqua, RD2117-01. All participants wore each of the 3 lenses for one week.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Robert Steffen</name_or_title>
      <organization>Bausch &amp; Lomb</organization>
      <phone>585 338 6399</phone>
      <email>robert.steffen@bausch.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

